Matthew K. Robinson's most recent trade in Immunome Inc was a trade of 58,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Matthew K. Robinson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Matthew K. Robinson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) |